Intranasal Coadministration of Live Lactococci Producing Interleukin-12 and a Major Cow's Milk Allergen Inhibits Allergic Reaction in Mice

ABSTRACT The Th1/Th2 balance deregulation toward a Th2 immune response plays a central role in allergy. We previously demonstrated that administration of recombinant Lactococcus lactis strains expressing bovine β-lactoglobulin (BLG), a major cow's milk allergen, partially prevents mice from sensitization. In the present study, we aimed to improve this preventive effect by coadministration of L. lactis BLG and a second recombinant L. lactis strain producing biologically active interleukin-12 (IL-12). This L. lactis strain producing IL-12 was previously used to enhance the Th1 immune response in a tumoral murine model (L. G. Bermúdez-Humarán et al., J. Immunol. 175:7297-7302, 2005). A comparison of the administration of either BLG alone or BLG in the presence of IL-12 was conducted. A BLG-specific primary Th1 immune response was observed only after intranasal coadministration of both L. lactis BLG and IL-12-producing L. lactis, as demonstrated by the induction of serum-specific immunoglobulin G2a (IgG2a) concomitant with gamma interferon secretion by splenocytes, confirming the adjuvanticity of IL-12-producing L. lactis. Immunized mice were further sensitized by intraperitoneal administration of purified BLG, and the allergic reaction was elicited by intranasal challenge with purified BLG. Mice pretreated with BLG in either the presence or the absence of IL-12 were rendered completely tolerant to further allergic sensitization and elicitation. Pretreatment with either L. lactis BLG or L. lactis BLG and IL-12-producing L. lactis induces specific anti-BLG IgG2a production in serum and bronchoalveolar lavage (BAL) fluid. Although specific serum IgE was not affected by these pretreatments, the levels of eosinophilia and IL-5 secretion in BAL fluid were significantly reduced after BLG challenge in the groups pretreated with L. lactis BLG and L. lactis BLG-IL-12-producing L. lactis, demonstrating a decreased allergic reaction. Our data demonstrate for the first time (i) the induction of a protective Th1 response by the association of L. lactis BLG and IL-12-producing L. lactis which inhibits the elicitation of the allergic reaction to BLG in mice and (ii) the efficiency of intranasal administration of BLG for the induction of tolerance.

[1]  B. Arulanandam,et al.  Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. , 2003, International immunopharmacology.

[2]  K. Hoffmann‐Sommergruber,et al.  Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. , 2003, Vaccine.

[3]  T. Nakahata,et al.  Limited Ability of Antigen-Specific Th1 Responses to Inhibit Th2 Cell Development In Vivo1 , 2005, The Journal of Immunology.

[4]  H. Mano,et al.  Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation. , 1999, Journal of immunology.

[5]  R. Coffman,et al.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. , 1986, Journal of immunology.

[6]  V. Azevedo,et al.  Improvement of bovine beta-lactoglobulin production and secretion by Lactococcus lactis. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  A. O’Garra,et al.  Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.

[8]  B. Ameredes,et al.  Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3 , 2004 .

[9]  M. Kleerebezem,et al.  Potential and opportunities for use of recombinant lactic acid bacteria in human health. , 2004, Advances in applied microbiology.

[10]  J Cohen,et al.  IL-12 Deaths: Explanation and a Puzzle , 1995, Science.

[11]  K. Arai,et al.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Chun-Keung Yu,et al.  Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. , 2002, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[13]  L. Bermúdez-Humarán,et al.  Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. , 2006, International immunopharmacology.

[14]  J. Leonard,et al.  Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. , 1997, Blood.

[15]  R. Ford,et al.  Cows' milk hypersensitivity: immediate and delayed onset clinical patterns. , 1983, Archives of disease in childhood.

[16]  J. D. de Vries,et al.  Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon‐γ , 1990, European journal of immunology.

[17]  D. Hill,et al.  Recovery from milk allergy in early childhood: antibody studies. , 1989, The Journal of pediatrics.

[18]  Paludan Interleukin‐4 and Interferon‐γ: The Quintessence of a Mutual Antagonistic Relationship , 1998, Scandinavian journal of immunology.

[19]  J. Leonard,et al.  Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production , 1997 .

[20]  Steve L. Taylor,et al.  Food allergy and the food industry , 2004, Current allergy and asthma reports.

[21]  E. Isolauri,et al.  Probiotics: a novel approach in the management of food allergy. , 1997, The Journal of allergy and clinical immunology.

[22]  J. Wal,et al.  Induction of Mucosal Immune Response after Intranasal or Oral Inoculation of Mice with Lactococcus lactis Producing Bovine Beta-Lactoglobulin , 2001, Clinical Diagnostic Laboratory Immunology.

[23]  B. Vargaftig,et al.  Elicitation of the allergic reaction in β‐lactoglobulin‐sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  J. Vuopio‐Varkila,et al.  Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria , 1996, Infection and immunity.

[25]  L. Zitvogel,et al.  Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical Trials , 1996, Annals of the New York Academy of Sciences.

[26]  Leaf Huang,et al.  Systemic production of IL‐12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo , 2001, The journal of gene medicine.

[27]  B. Arulanandam,et al.  Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery. , 1999, Vaccine.

[28]  L. Bjermer,et al.  Current and Emerging Nonsteroidal Anti-Inflammatory Therapies Targeting Specific Mechanisms in Asthma and Allergy , 2004, Treatments in respiratory medicine.

[29]  G. Matsuzaki,et al.  Differential effects of viable and killed bacteria on IL-12 expression of macrophages. , 1996, Journal of immunology.

[30]  J. Wal,et al.  Two-site enzyme immunometric assays for determination of native and denatured beta-lactoglobulin. , 1998, Journal of immunological methods.

[31]  J. Wal,et al.  Genetic Immunisation with Bovine β-Lactoglobulin cDNA Induces a Preventive and Persistent Inhibition of Specific Anti-BLG IgE Response in Mice , 2001, International Archives of Allergy and Immunology.

[32]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[33]  B. Arulanandam,et al.  Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. , 1999, The Journal of infectious diseases.

[34]  J. Wal,et al.  Oral administration of recombinant Lactococcus lactis expressing bovine β‐lactoglobulin partially prevents mice from sensitization , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  Y. Le Loir,et al.  Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production , 2003, Infection and Immunity.

[36]  G. Corthier,et al.  Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines , 2004 .

[37]  M. Miller,et al.  Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. , 1996, Journal of immunology.

[38]  S. Rabot,et al.  A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors , 2005, The Journal of Immunology.

[39]  Y. Le Loir,et al.  Characterization of a Lactococcus lactis Strain That Secretes a Major Epitope of Bovine Beta-Lactoglobulin and Evaluation of Its Immunogenicity in Mice , 2003, Applied and Environmental Microbiology.

[40]  J. Laman,et al.  Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. , 2000, Vaccine.

[41]  R. E. Wiley,et al.  Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. , 2004, American journal of respiratory and critical care medicine.

[42]  M. Shibamori,et al.  Intranasal mite allergen induces allergic asthma-like responses in NC/Nga mice. , 2006, Life sciences.

[43]  M. Jordana,et al.  Chronic Exposure to Innocuous Antigen in Sensitized Mice Leads to Suppressed Airway Eosinophilia That Is Reversed by Granulocyte Macrophage Colony-Stimulating Factor1 , 2002, The Journal of Immunology.

[44]  H. Renz,et al.  Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. , 2005, The Journal of allergy and clinical immunology.

[45]  M. Russo,et al.  Hierarchical suppression of asthma-like responses by mucosal tolerance. , 2006, The Journal of allergy and clinical immunology.

[46]  H. Gascan,et al.  Regulation of Human IgE synthesis , 1991, Annals of the New York Academy of Sciences.

[47]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[48]  B. Vargaftig,et al.  Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[49]  H. Eichler,et al.  Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[50]  Y. Charng,et al.  Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria. , 2006, Vaccine.

[51]  J. Wal,et al.  Evaluation of a high IgE-responder mouse model of allergy to bovine beta-lactoglobulin (BLG): development of sandwich immunoassays for total and allergen-specific IgE, IgG1 and IgG2a in BLG-sensitized mice. , 2000, Journal of immunological methods.

[52]  S. Issazadeh-Navikas,et al.  Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. , 2003, The Journal of allergy and clinical immunology.

[53]  L. Schwartz,et al.  Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[54]  B. Ameredes,et al.  Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. , 2004, The Journal of clinical investigation.

[55]  T. Okamoto,et al.  Survival of lactococci during passage through mouse digestive tract. , 2003, Canadian journal of microbiology.

[56]  A. Mercenier,et al.  Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. , 2002, The Journal of allergy and clinical immunology.

[57]  J. Holloway,et al.  Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.

[58]  G. Ruthel,et al.  Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Hachimura,et al.  Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[60]  P. Renault,et al.  Survival, Physiology, and Lysis ofLactococcus lactis in the Digestive Tract , 1999, Applied and Environmental Microbiology.

[61]  M. Jordana,et al.  Inhalation Tolerance Is Induced Selectively in Thoracic Lymph Nodes but Executed Pervasively at Distant Mucosal and Nonmucosal Tissues1 , 2006, The Journal of Immunology.